La EMA ha publicado la versión 3.21 del capítulo 3.II -‘XEVPMR User Guidance’- del documento de la ‘Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2) of Regulation (EC) No. 726/2004 ’
